肝脏脂肪与炎症及氧化应激标志物相关:弗雷明汉心脏研究数据分析
基于弗雷明汉心脏研究2482名接受计算机断层扫描和14种血清炎症标志物检测的参与者,采用肝脏:体模比识别影像学肝脂肪证据,多变量线性回归分析显示肝脂肪与高敏C反应蛋白、尿异前列腺素、白细胞介素6、细胞间黏附分子1和P选择素相关,校正体重指数或内脏脂肪后关联仍具统计学显著性。
要点
- 无已知肝病的肝脂肪变个体血清全身炎症标志物平均浓度更高。
- 肝脂肪与高敏C反应蛋白、尿异前列腺素、白细胞介素6、细胞间黏附分子1和P选择素相关。
- 校正体重指数或内脏脂肪后所有关联仍具统计学显著性。
核心结论
- 在社区队列中,无已知肝病的肝脂肪变个体血清全身炎症标志物平均浓度更高。
- 需要研究确定治疗肝脂肪变是否减轻全身炎症。
研究设计与样本
- 从弗雷明汉心脏研究收集2482名参与者的数据,平均年龄51±11岁,51%为女性。
- 参与者接受计算机断层扫描并测量14种血清全身炎症标志物。
- 排除大量饮酒者,使用肝脏:体模比识别影像学肝脂肪证据。
- 主要协变量包括年龄、性别、吸烟、酒精、阿司匹林使用、高血压、血脂异常、糖尿病和心血管疾病,体重指数和内脏脂肪为次要协变量。
- 采用多变量线性回归模型评估肝脂肪与全身炎症标志物的关联。
主要发现
- 在多变量校正模型中,肝脂肪与高敏C反应蛋白相关(P < .001)。
- 肝脂肪与尿异前列腺素相关(P < .001)。
- 肝脂肪与白细胞介素6相关(P < .001)。
- 肝脂肪与细胞间黏附分子1相关(P < .001)。
- 肝脂肪与P选择素相关(P = .002)。
局限性
- 需要研究确定治疗肝脂肪变是否减轻全身炎症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Nonalcoholic fatty liver disease is an inflammatory condition that results in progressive liver disease. It is unknown if individuals with hepatic steatosis, but not known to have liver disease, have higher serum concentrations of markers of systemic inflammation and oxidative stress. METHODS: We collected data from 2482 participants from the Framingham Heart Study (mean age, 51 ± 11 y; 51% women) who underwent computed tomography and measurement of 14 serum markers of systemic inflammation. Heavy alcohol users were excluded. The liver:phantom ratio (a continuous parameter of liver attenuation relative to a calibration phantom) was used to identify individuals with radiographic evidence of liver fat. Primary covariates included age, sex, smoking, alcohol, aspirin use, hypertension, dyslipidemia, diabetes, and cardiovascular disease. Body mass index and visceral fat were secondary covariates. We used multivariable linear regression models to assess the association between liver fat and systemic inflammatory markers. RESULTS: In multivariable-adjusted models, liver fat was associated with the following inflammatory markers: high-sensitivity C-reactive protein (P < .001), urinary isoprostanes (P < .001), interleukin 6 (P < .001), intercellular adhesion molecule 1 (P < .001), and P-selectin (P = .002). Additional adjustment for body mass index or visceral fat attenuated the results slightly, although all associations remained statistically significant (P for all ≤ .01). CONCLUSIONS: In a community-based cohort, individuals with hepatic steatosis without known liver disease had higher mean serum concentrations of systemic markers of inflammation. Studies are needed to determine whether treatment of hepatic steatosis reduces systemic inflammation.
引用
- Fricker ZP, Pedley A, Massaro JM, et al. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. Clin Gastroenterol Hepatol. 2018. PMID: 30476583. doi:10.1016/j.cgh.2018.11.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。